AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...

$1.5 million is the 'magic number' for retirement savings—here's how long it lasts in every U.S. state ...

Put your money to work and make it make you money. Unfortunately, it’s not going to make you much money in a standard ...

Millions of Americans face the difficult decision of choosing between their health and their finances. Prescription ...

AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with trenibotulinumtoxinE (TrenibotE), a short-acting successor to its blockbuster Botox brand, that has just ...

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

The long-term accommodations sector shows promise for stable growth amid rockier economic times, Choice’s CEO shared during a ...

The Newport Beach aesthetics company launched Evolysse Form and Evolysse Smooth, which refers to its injectable hyaluronic ...

Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million. As ...

The global sales of dermal fillers are estimated to be worth USD 6.4 billion in 2024 and anticipated to reach a value of USD 8.8 billion by 2034. Sales are projected to rise at a CAGR of 3.3% over the ...

NEW YORK, DE, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- The global breast reconstruction surgery market is forecast to grow from USD 4.9 billion in 2025 to USD 10.1 billion by 2035, advancing ...

The 10th anniversary of Forbes’ list marked another record year for these queens of capitalism, with a 20% jump in ...